Solara Active Pharma Sciences Ltd. (SOLARA) Quarterly Results: Q1 FY27
Quick answer: Solara Active Pharma Sciences Ltd. (NSE: SOLARA) reported Q1 FY27 revenue of ₹384 Cr and net profit of ₹16 Cr, with earnings per share (EPS) of ₹3.39, announced on 23-Jul-26.
That works out to a net profit margin of about 4.2% for the quarter.
Note: figures are pulled automatically from company filings and may lag or contain gaps. Verify on NSE or BSE. Not investment advice.
How to read Solara Active Pharma Sciences Ltd.'s Q1 FY27 results
Revenue of ₹384 Cr is what Solara Active Pharma Sciences Ltd. earned before costs. Net profit of ₹16 Cr is what remained for shareholders after expenses, interest and tax. Dividing one by the other gives a net margin of about 4.2%, a quick gauge of how much of each rupee of sales is kept as profit.
New to results? Read our guide on how to read quarterly results, see the full results list or the dividend calendar.
Solara Active Pharma Sciences Ltd. results FAQs
What were Solara Active Pharma Sciences Ltd.'s Q1 FY27 results?
Solara Active Pharma Sciences Ltd. (NSE: SOLARA) reported Q1 FY27 revenue of ₹384 Cr and net profit of ₹16 Cr, with earnings per share (EPS) of ₹3.39, announced on 23-Jul-26.
What is Solara Active Pharma Sciences Ltd.'s EPS for Q1 FY27?
Solara Active Pharma Sciences Ltd.'s earnings per share for Q1 FY27 was ₹3.39. EPS is net profit divided by the number of outstanding shares.
When did Solara Active Pharma Sciences Ltd. announce its Q1 FY27 results?
Solara Active Pharma Sciences Ltd. announced its Q1 FY27 results on 23-Jul-26.
What is Solara Active Pharma Sciences Ltd.'s net profit margin?
On the reported figures, Solara Active Pharma Sciences Ltd.'s Q1 FY27 net profit margin is about 4.2% (net profit ÷ revenue).